Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Allogene Therapeutics announced participation in three investor conferences in November and December 2026: the UBS Global Biopharma Conference (Nov 16), the Jefferies Global Healthcare Conference (Nov 18), and the Piper Sandler 38th Annual Healthcare Conference (Dec 2). Available webcasts will be posted on the company's website with replays for approximately 30 days.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.